Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (71)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Eiberg, H.
Right arrow Articles by Rosenberg, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eiberg, H.
Right arrow Articles by Rosenberg, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

OTHER

Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis

Hans Eiberg*, Birgit Kjer1, Poul Kjer2 and Thomas Rosenberg2

University Institute of Medical Biochemistry & Genetics, Department of Medical Genetics B24.4, Genome Group, Danish Centre for Genome Research Blegdamsvej 3, 2200 Copenhagen N, Denmark 1Department of Ophthalmology, Hvidovre Hospital Hvidovre, Copenhagen 2National Eye Clinic for the Visually Impaired Hellerup, Copenhagen, Denmark

* To whom correspondence should be addressed

Received March 8, 1994; Revised April 5, 1994; Accepted April 5, 1994

Dominant optic atrophy, type Kjer (McKusick no. 165500) is an autosomal dominant eye disease. The disease is characterized by moderate to severe visual impairment with an insidious onset during the first decade of life, blue-yellow dyschromatopsia and centrocecal scotoma of varying density. We examined three extended Danish pedigrees using highly informative short tandem repeat polymorphisms and found linkage of the disease gene (OPA1) to a (CA)n dinucleotide repeat polymorphism at locus D3S1314 (Zmax = 10.34 at {theta}M=F =0.075). Using two additional chromosome 3 markers we were able to map the OPA1 gene in the region between D3S1314 and D3S1265 (3q28-qter).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
M. V. Alavi, S. Bette, S. Schimpf, F. Schuettauf, U. Schraermeyer, H. F. Wehrl, L. Ruttiger, S. C. Beck, F. Tonagel, B. J. Pichler, et al.
A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy
Brain, April 1, 2007; 130(4): 1029 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
H Eiberg, L Hansen, B Kjer, T Hansen, O Pedersen, M Bille, T Rosenberg, and L Tranebjaerg
Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene.
J. Med. Genet., May 1, 2006; 43(5): 435 - 440.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Aijaz, L. Erskine, G. Jeffery, S. S. Bhattacharya, and M. Votruba
Developmental Expression Profile of the Optic Atrophy Gene Product: OPA1 Is Not Localized Exclusively in the Mammalian Retinal Ganglion Cell Layer
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1667 - 1673.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. Gong, O. Kosoko-Lasaki, G. R. Haynatzki, and M. R. Wilson
Genetic dissection of myocilin glaucoma
Hum. Mol. Genet., April 1, 2004; 13(90001): R91 - 102.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M Votruba, D Thiselton, and S S Bhattacharya
Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy
Br. J. Ophthalmol., January 1, 2003; 87(1): 48 - 53.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. L. Thiselton, C. Alexander, J.-W. Taanman, S. Brooks, T. Rosenberg, H. Eiberg, S. Andreasson, N. Van Regemorter, F. L. Munier, A. T. Moore, et al.
A Comprehensive Survey of Mutations in the OPA1 Gene in Patients with Autosomal Dominant Optic Atrophy
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1715 - 1724.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
U. E.A. Pesch, B. Leo-Kottler, S. Mayer, B. Jurklies, U. Kellner, E. Apfelstedt-Sylla, E. Zrenner, C. Alexander, and B. Wissinger
OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance
Hum. Mol. Genet., June 1, 2001; 10(13): 1359 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Toomes, N. J. Marchbank, D. A. Mackey, J. E. Craig, R. A. Newbury-Ecob, C. P. Bennett, C. J. Vize, S. P. Desai, G. C.M. Black, N. Patel, et al.
Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy
Hum. Mol. Genet., June 1, 2001; 10(13): 1369 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
J. B. Kerrison, V. J. Arnould, J. M. Ferraz Sallum, M. R. Vagefi, M. M. Barmada, Y. Li, D. Zhu, and I. H. Maumenee
Genetic Heterogeneity of Dominant Optic Atrophy, Kjer Type: Identification of a Second Locus on Chromosome 18q12.2-12.3
Arch Ophthalmol, June 1, 1999; 117(6): 805 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. Iannaccone and M. Votruba
Clinical and Functional Features of Patients With Dominant Optic Atrophy
Arch Ophthalmol, February 1, 1999; 117(2): 287 - 288.
[Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. Votruba, F. W. Fitzke, G. E. Holder, A. Carter, S. S. Bhattacharya, and A. T. Moore
Clinical Features in Affected Individuals From 21 Pedigrees With Dominant Optic Atrophy
Arch Ophthalmol, March 1, 1998; 116(3): 351 - 358.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.